Drug Trial Radar · NCT06585787
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
Last checked: Nov 20, 2026Latest source record: Oct 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
406
Planned (sponsor's estimate)
Start
Sep 26, 2024
Primary completion
Nov 24, 2026
Study completion Dec 22, 2026
Sponsor
- Lead sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb companyBristol Myers Squibb (BMY)
- Sponsor type
- Industry
- First posted
- Sep 19, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 55 years, up to 90 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety and efficacy of KarXT in adult participants with mild to severe Alzheimer's Disease (AD) with moderate to severe psychosis related to AD.
Conditions
- Alzheimer Disease
Interventions
KarXTDrug
Specified dose on specified days
PlaceboDrug
Specified dose on specified days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline in Neuropsychiatric Inventory-Clinician: Hallucinations and Delusions (NPI-C: H+D) scoreTime frame: Up to Week 14
Locations
296 sites in 25 countries. Site status is shown where the registry gives one.
Local Institution - 1227
Chandler, Arizona · Completed
Gilbert Neurology Partners - PLLC - Avacare
Gilbert, Arizona · Recruiting
Banner Alzheimer's Institute
Phoenix, Arizona · Recruiting
Local Institution - 1220
Scottsdale, Arizona · Completed
Advanced Research Center, Inc.
Anaheim, California · Recruiting
Inland Psychiatric Medical Group (IPMG)-Chino
Chino, California · Recruiting
Local Institution - 1230
Long Beach, California · Completed
USC - The Memory and Aging Center (MAC) - Alzheimer Disease Research Center (ADRC)
Los Angeles, California · Recruiting
Local Institution - 1219
Los Angeles, California · Withdrawn
Local Institution - 1001
Orange, California · Completed
Local Institution - 1228
Orange, California · Completed
Local Institution - 1043
Pasadena, California · Active not recruiting
Local Institution - 1213
Rancho Cucamonga, California · Active not recruiting
University of Connecticut Health Center
Farmington, Connecticut · Recruiting
Local Institution - 1225
Atlantis, Florida · Completed
Envision Trials LLC
Bonita Springs, Florida · Recruiting
Local Institution - 1138
Cutler Bay, Florida · Active not recruiting
Arrow Clinical Trials
Daytona Beach, Florida · Recruiting
Local Institution - 1224
Deerfield Beach, Florida · Completed
Local Institution - 1164
Doral, Florida · Active not recruiting
Local Institution - 1264
Gulf Breeze, Florida · Not yet recruiting
Local Institution - 1120
Hialeah, Florida · Active not recruiting
Local Institution - 1237
Hialeah, Florida · Completed
Local Institution - 1229
Homestead, Florida · Active not recruiting
Local Institution - 1040
Lady Lake, Florida · Completed
Local Institution - 1159
Miami, Florida · Active not recruiting
Local Institution - 1021
Miami, Florida · Active not recruiting
Local Institution - 1125
Miami, Florida · Active not recruiting
Local Institution - 1236
Miami, Florida · Active not recruiting
Local Institution - 1115
Miami, Florida · Active not recruiting
Local Institution - 1010
Miami, Florida · Completed
Local Institution - 1143
Miami, Florida · Completed
Local Institution - 1113
Miami, Florida · Active not recruiting
Local Institution - 1129
Miami, Florida · Active not recruiting
Local Institution - 1150
Miami, Florida · Active not recruiting
Local Institution - 1006
Miami, Florida · Active not recruiting
Local Institution - 1111
Miami, Florida · Active not recruiting
Local Institution - 1158
Miami, Florida · Completed
Local Institution - 1235
Miami, Florida · Completed
Local Institution - 1147
Miami, Florida · Completed
Showing 40 of 296 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.